Procter & Gamble price target raised to $181 from $170 at JPMorgan

JPMorgan raised the firm’s price target on Procter & Gamble to $181 from $170 and keeps an Overweight rating on the shares as part of a Q2 preview last week for the household and personal care space. The firm expects another “subdued” earnings season for the 15 stocks it covers, saying most companies are seeing a deceleration in organic sales sequentially as pricing benefits rolled over and private label regained share. However, the sector continues to look relatively better versus beverages, and the high-quality names are good places to “hide,” the analyst tells investors in a research note. JPMorgan established December 2025 price targets across the group.